Did you know?

The average stock forecast for Beam Therapeutics Inc (BEAM) is 54.77 USD. This price target corresponds to an upside of 85.21%. The range of stock …Beam Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030. In the last three years, Beam Therapeutics's EPS has grown, increasing from $-2.49 to $-4.13 – an increase of 65.86%. For the next year, 13 analysts project Beam Therapeutics's EPS to drop by 3.39%, reaching $-3.99. By 2030, professionals believe that Beam Therapeutics's ...In the field of construction, the use of steel beams is vital for providing structural support and stability to buildings. When it comes to steel beams, using standardized sizes has numerous benefits.Infibeam Avenue Share Price: Find the latest news on Infibeam Avenue Stock Price. Get all the information on Infibeam Avenue with historic price charts for ...TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comDrug-developer Vaxart ( VXRT -1.13%) is expected to increase its annual sales from the $4.05 million reported in 2020 to a consensus estimate of $1.047 billion by mid-decade. That's an increase of ...Track Beam Therapeutics Inc (BEAM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsThe Fly Beam Therapeutics price target lowered to $26 from $35 at Barclays. 21d ago. Press Releases Beam Therapeutics Reports Pipeline and Business Updates and Third Quarter 2023 Financial Results. 22d ago. Press Releases Beam Therapeutics to Participate in 2023 Jefferies London Healthcare Conference. 22d ago.Nov 30, 2023 · Beam Therapeutics Inc. (BEAM) Stock Price, Quote & News - Stock Analysis 29.67 +0.20 (0.68%) At close: Nov 24, 2023, 1:00 PM 30.22 +0.55 (1.85%) After-hours: Nov 24, 2023, 4:42 PM EST Overview Financials Statistics Profile Chart 1Y Max 0.68% ( 1D) About BEAM Price target. 49.67 0.00 0.00%. The 12 analysts offering 1 year price forecasts for BEAM have a max estimate of — and a min estimate of —. The first Wood-backed stock we’ll look at is Beam Therapeutics, ... Going by the $70.89 average target, the shares will climb ~62% higher in the year ahead. (See BEAM stock forecast)Find real-time ROKU - Roku Inc stock quotes, company profile, news and forecasts from CNN Business.Stock Price Forecast The 12 analysts offering 12-month price forecasts for Beam Therapeutics Inc have a median target of 46.50, with a high estimate of 95.00 and a low estimate of 19.00. The median estimate represents a +57.09% increase from the last price of 29.60.Also, the market prices MUSA at a forward multiple of 11.67, below the sector median value of 15.34 times. Thus, MUSA at least ranks as one of the stocks to watch. Finally, Wall Street analysts ...[LIVE] Beam Telecom share price details along with futures & options quotes. Get detailed report, 52 Week High / Low and company news on Nirmal Bang.Find the latest Beam Global (BEEM) stock quote, history, news and other vital information to help you with your stock trading and investing.SmartAssetPaid Partner. Find real-time FSR - Fisker Inc stock quotes, company profile, news and forecasts from CNN Business.BEAM - Beam Therapeutics Inc Stock - Stock Price, Institutional Ownership, Shareholders (NASDAQ)According to the issued ratings of 11 analysts in the last year, the consensus rating for Beam Therapeutics stock is Hold based on the current 6 hold ratings and 5 buy ratings for BEAM. The average twelve-month price prediction for Beam Therapeutics is $48.80 with a high price target of $105.00 and a low price target of $20.00. Learn more on ...7 brokerages have issued 1 year price objectives for Sangamo Therapeutics' stock. Their SGMO share price targets range from $1.00 to $10.00. On average, they expect the company's stock price to reach $4.68 in the next year. This suggests a possible upside of 1,036.9% from the stock's current price.Jun 13, 2022 - Beam Therapeutics stock forecast & analyst price target predictions based on 9 analysts offering 12-months price targets for BEAM in the last 3 months. Pinterest. Today. Watch. Shop. Explore. When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with ...Inflation and geopolitical conflicts remain risks for investors. The stock market is entering the end of 2023 with major positive momentum, including an eight-day winning streak for the S&P 500 in ...Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.Strong Buy Chart & Forecast Earnings Dividends Insider Trading Signals Historical Prices Predictions News Profile 3m (25.40%) 12m (-35.51%) Bollinger Bands …

The stock of Beam Therapeutics (BEAM 5.31%), a clinical-stage genetic base-editing company, has shed 48% of its value relative to its 52-week high in recent weeks.14,305.03 +78.81(+0.55%) Russell 2000 1,862.64 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Beam Therapeutics Inc. (BEAM) NasdaqGS - NasdaqGS Real Time Price.... Infibeam Avenue Share Price: Find the latest news on Infibeam Avenue Stock Price. Get all the information on Infibeam Avenue with historic price charts for ...Find real-time NIO - NIO Inc stock quotes, company profile, news and forecasts from CNN Business.

Beam Therapeutics (BEAM) Stock Forecast & Price Target $29.47 +1.52 (+5.44%) (As of 11/22/2023 ET) Compare Today's Range $28.24 $29.84 50-Day Range …Find real-time DDOG - Datadog Inc stock quotes, company profile, news and forecasts from CNN Business. ... EPS forecast (this quarter) $0.32: Annual revenue (last year) $1.7B: Annual profit (last ...Find the latest Quantum-Si incorporated (QSI) stock quote, history, news and other vital information to help you with your stock trading and investing.…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. BEAM | Complete Beam Therapeutics Inc. stock new. Possible cause: Nov 29, 2023 · 3 Wall Street research analysts have issued 12-month price targets .